Prevalent Breast Cancer Patients With a Homozygous Mutant Status for CYP2D6*4: Response and Biomarkers in Tamoxifen Users

Breast Cancer Research and Treatment - Netherlands
doi 10.1007/s10549-009-0463-5
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Comprehensive CYP2D6 Genotype and Adherence Affect Outcome in Breast Cancer Patients Treated With Tamoxifen Monotherapy

Breast Cancer Research and Treatment
Cancer ResearchOncology
2010English

Pharmacogenetics and Breast Cancer Endocrine Therapy: CYP2D6 as a Predictive Factor for Tamoxifen Metabolism and Drug Response?

Expert Reviews in Molecular Medicine
Molecular MedicineMolecular Biology
2008English

Improved Prediction of Endoxifen Metabolism by CYP2D6 Genotype in Breast Cancer Patients Treated With Tamoxifen

Frontiers in Pharmacology
Pharmacology
2017English

CYP2D6 Genotyping and Tamoxifen in the Treatment of Post-Menopausal Breast Cancer - A Reply

British Journal of Clinical Pharmacology
Pharmacology
2014English

Composite Functional Genetic and Comedication CYP2D6 Activity Score in Predicting Tamoxifen Drug Exposure Among Breast Cancer Patients

Journal of Clinical Pharmacology
Pharmacology
2010English

Tamoxifen and Mastectomy for Elderly Patients With Operable Breast Cancer.

BMJ
1988English

Investigational Drug Combined With Chemotherapy Improves Response in Patients With BRCA -Mutant Breast Cancer

Cancer
Cancer ResearchOncology
2017English

The Relationship Between the CYP2D6 Polymorphisms and Tamoxifen Efficacy in Adjuvant Endocrine Therapy of Breast Cancer Patients in Chinese Han Population

International Journal of Cancer
Cancer ResearchOncology
2018English

C–X–C Ligand 10 and C–X–C Receptor 3 Status Can Predict Tamoxifen Treatment Response in Breast Cancer Patients

Breast Cancer Research and Treatment
Cancer ResearchOncology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy